EP PerMed: the call for research, innovation and technology is about to be launched! -ČR ANNOUNCEMENT OF A NEW CALL FOR PROPOSALS FOR RESEARCH AND INNOVATION IS AZV .

The European Partnership for Personalised Medicine (PerMed), a partnership whose vision is to improve health outcomes in sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens and society, will launch a joint transnational call "Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)" in early October 2025 .

The aim of the call is to:

linking businesses with clinical stakeholders, including healthcare providers, patients and researchers, to test innovative solutions in controlled real-world settings; these solutions should address specific and clearly defined needs in the care of patients with multiple chronic conditions that require long-term, coordinated care (multimorbidity);
Fund innovative projects in the field of human health, focusing on the use of heterogeneous (multimodal) data in personalised medicine approaches, with the aim of more efficient and individualised management of care for patients with two or more chronic diseases requiring continuous healthcare (multimorbidity).

Projects will address at least one of the following aspects:

recognising or describing the presence of other diseases that occur together in patients with chronic diseases;
diagnosing or monitoring disease progression, including periods of improvement and relapse;
supporting the transition from inpatient to outpatient care through remote monitoring or reporting using wearable devices or other technical tools;
decision support for treatment choices (e.g. type and dose of treatment);
monitoring and managing multiple treatments (including drug combinations) to increase the effectiveness of treatment or reduce the risk of side effects and harmful drug combinations;
ensuring adherence to long-term treatment regimens.

Project proposals must include a clearly described and high-quality strategy for the collection, processing and use of diverse (multimodal) health data.

Transnational project consortia must include a clinical partner and at least one SME or industrial partner.

Large-scale clinical trials are not covered by this call and will not be supported under this call.

The Ministry of Health / Agency for Health Research ČR will participate in this call!

Currently, national rules and conditions for Czech applicants are being prepared, which will be based on the Programme for the Support of Applied Health Research for 2024-2030: Subprogramme 3: European Partnerships in Health, and will be published on the website of AZV ČR by the date of the call announcement. We recommend to keep an eye on the AZV ČR website and also on the official website of the EP PerMed call.

The MoHCR will support Czech applicants through the national budget allocation. The total amount for the call will be EUR 250 000.

Only transnational projects will be funded. The call will be a two-round call.

Provisional timetable of the call:

Early October 2025: launch of the call
28 October 2025: Information day for potential applicants
12.1.2026 (14.00 CET): Deadline for submission of pre-proposals
Mid-March 2026: Communication of results of pre-proposals and call for full proposals
27 April 2026 (14.00 CEST): Deadline for submission of full proposals
End of June 2026: Rebuttal stage
September 2026: Announcement of funding decision
End 2026/beginning 2027: Expected start of projects (subject to national/regional conditions)

More information on the objectives of the call, the themes, the countries that have expressed interest in participating, the national contact points as well as other specific conditions can be found on the official PerMed EP website and in the background document for the call, which can be downloaded here.